SAN JOSE, Calif., Jan. 21, 2025 /PRNewswire/ -- Harmonic (NASDAQ: HLIT) today announced it will release its fourth quarter and full year 2024 financial results after the market close on Monday, ...
SAN JOSE, Calif., Feb. 10, 2025 /PRNewswire/ — Harmonic Inc. (NASDAQ: HLIT) today announced its unaudited results for the fourth quarter and fiscal year ended December 31, 2024. “Harmonic achieved ...
The Company intends to continue THB335 development activities through the first half of 2025 to prepare for the initiation of a 12-week, placebo-controlled Phase 2 study in CSU by mid-year 2025. Key ...
(1) Components may not sum to total due to rounding. (2) Consolidated Segment Adjusted EBITDA is a Non-GAAP financial measure. Refer to "Use of Non-GAAP Financial ...
SAN FRANCISCO, March 27, 2025 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today reported ...
SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback